CClinicalTrials.gg
Not yet recruitingNCT07135830Updated Aug 22, 2025

Ashwagandha (Withania Somnifera) and Its Effects on Recovery Perceived and Muscle Strength in Male Handball Players

An interventional study of Handball training in Strength Training Adaptations and Recovery, sponsored by University of Maia. Not yet recruiting. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by University of Maia · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

This study aims to assess the potential recovery and strength effects of male handball players.

02

Conditions studied

  • Strength Training Adaptations
  • Recovery

Keywords

  • ashwagandha
  • strength
  • recovery
  • handball
03

In context

Lead sponsor

University of Maia is the lead sponsor of 21 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Handball players competing nationally

Exclusion criteria

Exclusion Criteria:

  • Injured athletes
  • Female athletes
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Ashwaggandha supplementation

    Participants in this group took one capsule per day containing 600 mg of ashwagandha

    Other: Handball training

  • Placebo comparator
    Placebo

    The placebo group consumed one capsule per day, identical in color and size to the ashwagandha capsules

    Other: Handball training

Interventions

  • OtherHandball training

    Athletes will perfrom their regular handball training

06

What researchers measure

Primary outcomes

  1. Rating of fatigue

    Time frame: Evaluations were conducted at three distinct time points: at baseline and at the 4th and 8th days after the baseline. Participants' levels of fatigue were measured using the Rating of Fatigue Scale, which includes 10 descriptors ranging from "not fatigue

  2. Perceived soreness

    Time frame: Evaluations were conducted at three distinct time points: at baseline and at the 4th and 8th days after the baseline. Perceived muscle soreness was evaluated using a 7-point Likert scale, where 0 indicated no soreness and 6 represented severe pain that s

  3. Knee Extension

    Time frame: Evaluations were conducted at three distinct time points: at baseline and at the 4th and 8th days after the baseline.

  4. Knee Flexion

    Time frame: Evaluations were conducted at three distinct time points: at baseline and at the 4th and 8th days after the baseline.

  5. Handgrip

    Time frame: Evaluations were conducted at three distinct time points: at baseline and at the 4th and 8th days after the baseline.

Secondary outcomes

  1. Total Quality Recovery

    Time frame: Evaluations were conducted at three distinct time points: at baseline and at the 4th and 8th days after the baseline.Perceived recovery was evaluated using the Total Quality Recovery (TQR) scale, which ranges from 6 to 20, with endpoints reflecting "very

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07135830
Lead sponsor
University of Maia
Responsible party
Filipe Silvano Pinto Maia (Principal investigator, University of Maia) — Principal investigator
First posted
Aug 22, 2025
Start date
Aug 25, 2025 (estimated)
Primary completion
Sep 10, 2025 (estimated)
Completion
Sep 30, 2025 (estimated)
Last update
Aug 22, 2025

Study contacts

Filipe Maia Principal Investigator
Contact
fmaia.dcd@umaia.pt
+351 22 986 6000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion